Four distinct epithelial cell types can be sorted by flow cytometry into single populations from normal and cancerous prostate tissues. They include luminal cells, basal cells, luminal-like cancer cells, and basal cell-like cancer cells. The luminal cell-like cancer cells are considered by be less malignant than the basal cell-like cancer cells based on their gene expression. Luminal cell-like cancer cells is the predominant population in localized tumors while the basal cell-0like cancer cells is a predominant population in some metastases. Sorted cells allow us to construct cell-type specific cDNA libraries for the identification of candidate cancer-associated genes in tumorigenesis and cancer progression by the powerful techniques of genomics. The four cell type libraries are augmented by libraries of prostate cancer xenografts of different virulence as represented by histology and growth characteristics. The new gene markers discovered will be used to investigate organ specificity in cancer metastasis, the interaction between tumor cells and bone microenvironment, androgen and growth factor dependence outlined in Projects II and IV. New serine proteases and useful cell surface molecules will be used in Project III. This project will generate a cell-type expression database useful to all areas of research in prostate biology. We will also attempt to completely define the transcriptosome of prostate tumor cells using a powerful new approach termed multiple sequence signature profiles. This procedure can place 500,000 cDNA sequences each on individual beads and sequence them for 16-20 bases. We will profile LNCaP cell lines, both androgen stimulated and androgen deprived, as well as LNCaP variant that is androgen independent. In each of these three cases we will determine about 1,000,000 sequences-more than enough to virtually define the entire transcriptosome.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA085859-01A2
Application #
6594325
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-05-01
Project End
2007-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Montgomery, Bruce; Tretiakova, Maria S; Joshua, Anthony M et al. (2017) Neoadjuvant Enzalutamide Prior to Prostatectomy. Clin Cancer Res 23:2169-2176
Martin, P L; Yin, J-J; Seng, V et al. (2017) Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer. Oncogene 36:525-533
Suominen, Mari I; Fagerlund, Katja M; Rissanen, Jukka P et al. (2017) Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models. Clin Cancer Res 23:4335-4346
Don-Doncow, Nicholas; Marginean, Felicia; Coleman, Ilsa et al. (2017) Expression of STAT3 in Prostate Cancer Metastases. Eur Urol 71:313-316
Haider, Maahum; Zhang, Xiaotun; Coleman, Ilsa et al. (2016) Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases. Clin Exp Metastasis 33:239-48
Wu, Yu; Davison, Jerry; Qu, Xiaoyu et al. (2016) Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer. Epigenetics 11:247-58
Van Allen, Eliezer M; Robinson, Dan; Morrissey, Colm et al. (2016) A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine. Oncotarget 7:52888-52899
Brocqueville, Guillaume; Chmelar, Renee S; Bauderlique-Le Roy, Hélène et al. (2016) s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells. Oncotarget 7:29228-44
Qu, Xiaoyu; Jeldres, Claudio; Glaskova, Lena et al. (2016) Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence. J Mol Diagn 18:215-24
Wu, Yu; Schoenborn, Jamie R; Morrissey, Colm et al. (2016) High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer. J Mol Diagn 18:131-43

Showing the most recent 10 out of 157 publications